Guide

Mounjaro Weight Loss Injection In Glasgow

Mounjaro Weight Loss Injection In Glasgow

Mounjaro is a weight loss injection that is licensed for use in weight loss alongside a reduced calorie diet and increased exercise. Mounjaro contains the active ingredient tirzepatide. Mounjaro is administered as a weekly injection and can be an effective aid to weight loss in those with a body mass index (BMI) over 30 or people with a BMI over 27 with weight related conditions such as high blood pressure. Buy Mounjaro Weight Loss Injection In Glasgow privately without prescription.

Key Facts About Mounjaro

Dose – Mounjaro is injected just ONCE weekly and follows a specific titration schedule slowly increasing the dose over a period of months

Type of Medicine – GLP-1 and GIP analogue

Active ingredient – Tirzepatide

Mechanism of action – tirzepatide suppresses the desire to eat and promotes the feeling of fullness after eating for longer which in turn helps you reduce your food intake. It also regulated blood sugar levels and increases the time it takes for your stomach to empty which makes you feel full for longer.

Side effects – nausea, diarrhoea, constipation, vomiting

Who are Mounjaro Weight Loss Injections suitable for?

Mounjaro can be used as an aid in weight loss alongside a reduced calorie diet and increased physical exercise for those with:

  • a BMI of over 30 (obese)
  • a BMI of 27 or more with a weight related condition such as high blood pressure.

You should speak with a doctor prior to using Mounjaro if you have: 

  • Severe gastroparesis
  • Eye conditions such diabetic retinopathy
  • Ever had pancreatitis (inflammation of the pancreas)

How does Tirzepatide work?

Mounjaro contains an active ingredient called tirzepatide which imitates two naturally occurring hormones in the body namely,

  • Glucagon-like peptide-1 (GLP-1)
  • Glucose-dependent insulinotropic polypeptide (GIP)

Mounjaro regulates appetite and promote the feeling of fullness. When you take Mounjaro, it talks to parts of your brain responsible for hunger which makes you feel less hungry and more satisfied, so you don’t crave food as much. Along with eating a reduced calorie diet and doing more exercise, Mounjaro Weight Loss Pens can help you lose weight. 

GLP-1 and GIP also increase insulin production which helps regulate blood sugar levels. Unregulated blood sugar levels can cause food graving hence, reducing the blood sugar spikes can be helpful when using Mounjaro.

In some people it was found that people taking the highest dose of Mounjaro (15mg) lost up to 22.5% of their body weight. It is important to remember that Mounjaro is not a magic drug and a commitment to eating a balanced diet, reducing snack intake and regular exercise alongside the use of Mounjaro is important.

Is Mounjaro effective To Help Me Lose Weight?

There have been several studies looking at the effectiveness of Mounjaro as a weight loss treatment. Those taking Mounjaro in addition to a balanced diet and exercise can expect to lose around 15-20% of their initial body weight. These results have been achieved by patients who complete treatment by maintaining the 15mg strength. 

clinical trial of the medicine carried our by Eli Lilly showed that patients who maintained the 10mg dose lost an average of 17% of their body weight and those who maintained the dose at 5mg lost around 15% of their body weight.

Mounjaro Dosing Schedule

Multiple doses of Mounjaro Weight Loss Pen are available as treatment typically begins at the lower dose and is titrated upwards over time. While most people would titrate up a dose every 4 weeks, this will be determined by how well you are tolerating the treatment and what side effects you may be experiencing. 

Wegovy vs Mounjaro

Wegovy (semaglutide) is a weekly weight loss medication that is licenced for use in weight loss. Both Wegovy and Mounjaro have been found to be an effective weight loss medicine and which one will work best for you will depend how your body reacts to them. While they both work in a similar way, Mounjaro is the first weight loss injection to act on two hormones as a dual agonist.

Mounjaro Pricing In Glasgow

Mounjaro Weight Loss Injection Consultation: FREE

Starter – x1 Month – 2.5mg – £199

5mg – x1 Month – £199

Starter – x2 Months supply (2.5mg + 5mg) – £388

7.5mg – x1 Month –  £249

10mg – x1 Month –  £279

12.5mg – x1 Month –  £310

15mg – x1 Month –  £325

How Much Weight Can You Lose on Mounjaro in 3 months?

How much weight you can lose on Mounjaro will depend on several factors including your diet, exercise and dosage.

Here, we’ll explore how much weight you could lose on average and what to expect across the first 13 weeks of treatment.

Weeks 1 – 2 (Starting Dose)

During the first 2 weeks of Mounjaro treatment, you’ll begin on the lowest starting dose of 2.5mg per week to help your body get used to the medication. Before you begin, you’ll need to pick a day and time that’s convenient for you to administer your injections. It’s best to pick a time that you know you’ll be available week on week.

In these 2 weeks, you will consider the necessary lifestyle changes needed alongside your treatment with Mounjaro for a successful weight loss journey. We’ll provide you with support materials, such as a weight loss tracker and food diary as part of the weight loss programme from Superdrug Online Doctor. These tools can help you monitor and track your treatment goals and outcomes.

During this period weight loss is likely to be modest as your appetite begins to decrease. You may also begin to experience some of the common Mounjaro side effects as your body adjusts to the medication, such as:

  • feeling or being sick
  • headache
  • diarrhoea
  • constipation
  • tummy pain
  • weakness or tiredness

Weeks 3 – 4

By weeks 3 and 4, Mounjaro should be fully active in your system, and you’ll likely start noticing its effects, particularly feeling fuller for longer periods between meals.

After 4 weeks of treatment, study shows that the average weight loss is around 4%, although this can vary from person to person.

Although you’ll still be on the low starting 2.5mg dose, you should continue to focus on eating balanced meals that contain lean proteins, fibre and healthy fats to support your weight loss targets.

Weeks 5 – 8

At this stage your Mounjaro dose is likely to be increased to 5mg per week. So, you may experience some of the side effects returning or increasing as your dose titrates (gradually increases) up. These should settle down again once your body gets used to the increased medication.

In most cases you can manage mild side effects at home with rest, drinking plenty of fluids, and taking over-the-counter painkillers, if needed. However, if you are concerned or finding any of the Mounjaro side effects difficult to manage, contact your doctor for advice.

After 8 weeks of Mounajro, the average weight loss is around 6%.

Weeks 9 – 12

After 8 weeks, if you have tolerated your current Mounjaro dose well, it may be increased to 7.5mg per week.

During these weeks, you are likely to start seeing some of the effects of weight loss. After 12 weeks of treatment, you might expect to lose up to 8% of your body weight.

Week 13 and beyond

From week 13 onwards, the weight loss results you can achieve with Mounjaro should become more consistent. Over time, you could lose up to 22.5% of your body weight, depending on how long you use the weight loss injection for and the maintenance dose you choose.

The maintenance dose for Mounjaro is 15mg per week, but you may choose to use a lower dose if you find it difficult to tolerate the side effects associated with a high dose, or if you think a lower dose is more effective for you.

What can affect your Mounjaro weight loss results

While Mounjaro is highly effective for weight loss, everybody’s weight loss journey looks different which means effects can vary from person to person. The reason for this is several factors can influence how well tirzepatide works for you, including your lifestyle, age, and overall health and wellbeing.

Understanding how these factors can impact your weight loss goals is crucial so you can make adjustments to maximise your success. 

Who Cannot Take Mounjaro in Glasgow?

Who cannot take Mounjaro? While effective, it’s not right for everyone. This article explores who should avoid it – for example, due to allergies, medical conditions and pregnancy.

Weight Loss Treatments in Glasgow

With the growing interest in treatments for weight management, Mounjaro has gained a lot of attention for its promising results. One study showed an average of 21% weight reduction in participants after three months.

But while many patients may benefit from this medication, unfortunately it’s not suitable for everyone.

In this article, we will take a closer look at who should not take Mounjaro. We’ll explore Mounjaro interactions, different medical conditions and risk factors that make it unsafe for some people. In some cases, the risk of side effects on Mounjaro may outweigh the benefits.

Who is Mounjaro Licensed For?

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Mounjaro (tirzepatide) for two main uses:

  1. Type 2 diabetes treatment
  2. Weight loss in adults – alongside a healthy, balanced diet and increased physical activity

Mounjaro is used to treat adults with obesity (with a BMI of 30 or higher).

It’s also licensed for use in overweight adults with a BMI of 27 or higher with at least one existing weight-related health condition. This might include high blood pressure, diabetes or heart disease.

Who Should Not Be on Mounjaro in Glasgow?

While most people tolerate Mounjaro injections well, the medication isn’t suitable for everyone.

For example, people with a history of certain medical conditions or known allergies should avoid it. It’s also not recommended during pregnancy, breastfeeding or for anyone under 18. Certain medications may interact with Mounjaro too, making it unsuitable.

People with Certain Health Conditions

Mounjaro is not suitable for people with certain health conditions, including:

  • Individuals with a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). This advice is based on studies where GLP-1 receptor activation caused thyroid tumours in rodents. While it hasn’t been found in humans, it does suggests a link between Mounjaro and thyroid cancer.
  • People with a history of pancreatitis. In some users, Mounjaro can cause acute pancreatitis. Signs of pancreatitis include severe stomach pain that may radiate to the back and vomiting.
  • Patients with severe gastrointestinal (stomach) disease, such as gastroparesis. Gastroparesis is a condition that leads to movement of food from the stomach to the small intestine slowing down. Since Mounjaro affects how quickly your stomach empties, it may make existing conditions worse.

Those With an Allergy to Tirzepatide or Mounjaro Ingredients

You shouldn’t use Mounjaro if you have a known allergy to tirzepatide, the active ingredient of Mounjaro. Or if you’ve had a reaction to any of the other ingredients in the injection.

Allergic reactions can range from mild skin rashes to severe anaphylaxis, a potentially life-threatening condition that requires immediate medical attention.

Let your healthcare provider know if you’ve ever experienced an allergic reaction after previous injections or medications. Symptoms include swelling, difficulty breathing, itching, or hives.

Always check the medication’s inactive ingredients before you start treatment. A full list of ingredients will come with the medication. Speak to a pharmacist or prescriber if you have concerns.

Pregnant or Breastfeeding People

Mounjaro is not recommended during pregnancy or while breastfeeding.

Currently, there is not enough research to confirm whether Mounjaro is safe for pregnant individuals. It’s unknown whether it passes into breast milk or what effects it may have on the baby.

If you’re planning to become pregnant, or are currently pregnant or breastfeeding, tell your GP or pharmacist.

Richard Wood, a pharmacist at Simple, says: “If you become pregnant during treatment despite additional safety measures like condoms and hormonal contraception, it is important that you stop Mounjaro as soon as you know you’re pregnant and seek support from your GP and Mounjaro provider.”

Children (Under 18s)

Mounjaro has not been approved for use in children or adolescents under the age of 18. It’s not known how safe or effective it is for people in this age group. And current clinical trials have mainly focused on adults.

As a result, prescribing Mounjaro to individuals under 18 is not recommended. Even for type 2 diabetes.

If a child or teenager is struggling with obesity or diabetes, a paediatric specialist should assess them. They can provide age-appropriate treatments and support. Until more research is available, Mounjaro remains strictly for adult use under the guidance of a qualified healthcare professional.

People on Certain Medications

Certain medications can interact with Mounjaro and affect how they work.

Mounjaro works by slowing down digestion. Because of this, Mounjaro can affect the absorption of oral medications. This includes some antibiotics and treatments for heart conditions.

It may also increase the risk of low blood sugar (hypoglycaemia) when used alongside some diabetic drugs, like insulin or sulfonylureas. This requires close monitoring and possible dose adjustments to help prevent any blood sugar drops.

Always share a complete list of your current medications with your prescriber or pharmacist. This will help avoid harmful interactions and ensure your treatment is safe and effective.

Side effects can also affect the absorption of some medication. So please let us, or your healthcare provider, know if you suffer from severe diarrhea or vomiting. They can give you advice on what to do next.

Why a Clinical Assessment is So Important

In the UK, Mounjaro is a prescription-only medicine (POM). This means a qualified healthcare professional has to prescribe it. And they have to dispense it through a regulated pharmacy.

This classification exists for a reason. Mounjaro affects critical systems in the body and is not suitable for everyone. A regulated provider will carry out a thorough clinical assessment to ensure the treatment is safe and appropriate. This involves reviewing your medical history, current medications and any underlying conditions.

It is crucial that you fill in all medical assessment forms as truthfully and fully as possible. Withholding information could put your health at serious risk. Buying from unregulated sources not only skips this essential process but also increases the risk of receiving unsafe products.

Your safety should always come first, so only trust licensed providers. For more information, this article explains how to buy medication safely online.

Is Mounjaro safe for weight loss in Glasgow?

Yes, Mounjaro is generally considered safe when used correctly and under medical supervision. Despite being relatively new for weight loss, Mounjaro has been used long-term as a diabetes treatment – the original purpose for glucagon-like peptide-1 (GLP-1) agonists.

The first GLP-1 medication for diabetes was approved in 2006, while Saxenda, now Nevolat, was approved in 2014 for weight loss, followed by Wegovy. Although they’re different medications, they all mimic the effects of the natural hormone GLP-1, helping you to lose weight by:

  • reducing appetite
  • slowing gastric emptying
  • improving insulin sensitivity

Mounjaro is the only dual-agonist as it mimics GLP-1 and gastric inhibitory peptide (GIP), which is thought to further enhance these effects and improve weight loss results.

Studies into Mounjaro’s safety

For Mounjaro, being approved as a weight loss medication means it has undergone rigorous clinical testing to assess its safety and efficacy.

Tirzepatide, the active ingredient in Mounjaro, was first studied in more than 6,200 type 2 diabetes patients as part of the SURPASS clinical trial program. In total, there were 5 trials (SURPASS 1 to 5). It was found to help blood glucose levels return to normal in up to 62% of people treated with the highest dose of 15mg per week, but participants were also losing weight. This led to the SURMOUNT trials, where Mounjaro was assessed for its benefits on weight loss.

Several SURMOUNT trials have been carried out since 2022. The first study demonstrated that, at the maximum maintenance dose over 72 weeks, the average weight loss was 22.5%. The study also concluded that there were no major safety concerns, with the most common side effects being mild to moderate gastrointestinal events.

These extensive studies and their results helped confirm that Mounjaro is a safe and effective treatment, leading to the Medicines and Healthcare products Regulatory Agency (MHRA) approval of its use for weight loss in 2023.

The best way to ensure the safety of Mounjaro is to take it exactly as it is prescribed.

Before you start treatment, a doctor must assess your suitability and ensure you are eligible for treatment. To get a prescription for Mounjaro from Superdrug Online Doctor, you must have a body mass index (BMI) of:

  • 30kg/m2 or more (obese)
  • 27kg/m2 or more (overweight) and a weight-related health issue such as high blood pressure

Can I get Mounjaro from my GP?

You may have seen the news about Tirzepatide (Mounjaro) now being available on prescription from your GP. While this is welcome news, in order to be eligible, the following criteria apply:

BMI of at least 40 and 4 out of 5 other health conditions:

  • Type 2 diabetes
  • High blood pressure
  • Heart disease
  • Obstructive sleep apnoea
  • Abnormal blood fats

Will I gain weight after stopping Mounjaro?

Yes, it is common to regain a significant portion of lost weight after stopping Mounjaro, with studies showing many individuals regain about two-thirds of the lost weight within a year, often due to returning hunger and “food noise”. While weight regain is common, it is not inevitable; long-term weight maintenance is possible through maintained healthy eating, regular exercise, and behavioral changes.

Like other weight-loss injections, Mounjaro mimics hormones in your body that slow down your digestion, lower your appetite and make you feel fuller after eating. This helps you eat less and lose weight.

When you stop taking the drug, your appetite returns to normal, and some people find they start eating more and regain the weight they lost while taking the drug.

Unlike other weight-loss injections, there’s currently no time limit on how long you can take Mounjaro if you’re part of the limited number of people who fit the criteria to be prescribed the drug on the NHS.

But there are other reasons people stop taking Mounjaro, such as side effects, or other medical reasons, and cost if they pay for the medicine privately.

Leave a Reply

Your email address will not be published. Required fields are marked *